Indication


FDA Panel Once Again Rejects New Indication For J&J Drug

FDA Panel Once Again Rejects New Indication For J&J Drug

The FDA’s Cardiovascular and Renal Drugs Advisory Committee once again turned down the supplemental new drug application for an...

Jan 16 2014, 5:36pm CST

Follow Us
Follow I4U News on Twitter
Follow I4U News on Facebook